Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof
US9249208B2 · kind B2 · utility
0Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 2012 |
| Grant date | Feb 2, 2016 |
| Priority date | — |
| Expiry date | Mar 11, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/75
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention relates to novel citrulline peptides derived from fibrin α and β chains which are recognizable by specific citrulline antiprotein autoantibodies (AAPC) of a rheumatoid arthritis (PR) and to the use thereof for detecting the presence of said specific PR AAPC in a biological sample.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.